Delivery Order SPE2DB20D3103-SPE2DB25FN4F7
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,399.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.39, is a Firm Fixed Price Delivery Order for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a performance period through March 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,100.48 firm-fixed-price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,841.24, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a medical product used in healthcare. The contract has a period of performance through February 20, 2025 and was awarded on February 19, 2025. This award is not associated with a set-aside program. The contract is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,060.00 firm-fixed-price delivery order is for the supply of 4562192687 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, with a completion date of September 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,782.68 firm-fixed-price delivery order is for the provision of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,819.84, is for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The award has a firm fixed price and is not designated with any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a ceiling value of $4,091.91 and a performance period through May 8, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any specific business category....
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order (contract #SPE2DB20D1047|SPE2DB24FF60Z) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564232214 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award, with a ceiling value of $5,772.01, has an ultimate completion date of April 11, 2024. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,071.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply KONVOMEP 2-84 MG/ML oral suspension (90 ml). This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities to support military...